NEW YORK, Dec 7 – Luminex has signed a multi-year licensing agreement with Hitachi for the worldwide distribution rights to its LabMap kit of reagents and instrumentation, Luminex announced Thursday.
Under the agreement, MiraiBio, formerly Hitachi Genetic Systems, will offer the LabMap assay detection products to its customers along with its microarray, bioimaging, bioinformatics, and spectroscopy technologies.
" The agreement with Luminex will extend our microarray product line to include a novel technology," Leonard Klevan, President of MiraiBio, said in a statement " Our expertise with laser-based systems and software development makes us a value-added provider of the LabMap system."
The LabMap technology uses microspheres, small lasers, digital processors, and software to perform up to 100 assays per drop of fluid.
This arrangement closely follows Luminex’s agreement with Qiagen to license and jointly develop fluorescent microspheres that immobilize functionally active proteins.
Luminex has licensed the LabMap technology to over 19 other companies as part of its core business strategy to commercialize the technology through establishing partnerships with other organizations.